Two Sigma Investments’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.89M Buy
2,302,001
+1,798,126
+357% +$3.19M ﹤0.01% 2201
2025
Q4
$716K Buy
503,875
+468,163
+1,311% +$682K ﹤0.01% 3123
2025
Q3
$58.6K Buy
+35,712
New +$39.7K ﹤0.01% 3526
2025
Q1
Sell
-134,138
Closed -$185K 3239
2024
Q4
$185K Sell
134,138
-548,242
-80% -$615K ﹤0.01% 2887
2024
Q3
$710K Sell
682,380
-151,861
-18% -$208K ﹤0.01% 2298
2024
Q2
$1.44M Sell
834,241
-627,772
-43% -$1.26M ﹤0.01% 1776
2024
Q1
$3.49M Buy
1,462,013
+11,661
+0.8% +$28.7K 0.01% 1166
2023
Q4
$4.83M Buy
+1,450,352
New +$3.88M 0.01% 1015
2023
Q2
Sell
-23,100
Closed -$158K 3040
2023
Q1
$158K Sell
23,100
-96,769
-81% -$751K ﹤0.01% 2605
2022
Q4
$949K Sell
119,869
-249,914
-68% -$1.92M ﹤0.01% 1722
2022
Q3
$3.55M Buy
369,783
+351,205
+1,890% +$3.55M 0.01% 890
2022
Q2
$135K Buy
+18,578
New +$162K ﹤0.01% 2231
2022
Q1
Sell
-15,600
Closed -$249K 2913
2021
Q4
$249K Buy
+15,600
New +$273K ﹤0.01% 3774
2021
Q2
Sell
-98,160
Closed -$1.43M 4094
2021
Q1
$1.43M Buy
+98,160
New +$1.67M ﹤0.01% 1987
2020
Q2
Sell
-157,591
Closed -$2.56M 2998
2020
Q1
$2.56M Sell
157,591
-496,281
-76% -$9.17M 0.02% 838
2019
Q4
$11.8M Buy
653,872
+563,679
+625% +$10.4M 0.04% 554
2019
Q3
$1.83M Sell
90,193
-69,666
-44% -$1.39M 0.01% 1512
2019
Q2
$3.53M Buy
159,859
+117,712
+279% +$2.04M 0.01% 1081
2019
Q1
$575K Sell
42,147
-191,958
-82% -$2.56M ﹤0.01% 2187
2018
Q4
$2.12M Buy
234,105
+74,690
+47% +$864K 0.01% 1213
2018
Q3
$2.63M Sell
159,415
-15,657
-9% -$278K 0.01% 1292
2018
Q2
$2.45M Buy
+175,072
New +$2.51M 0.01% 1478
2017
Q1
Sell
-115,480
Closed -$3.25M 2940
2016
Q4
$3.25M Buy
+115,480
New +$3.23M 0.01% 1128

Other funds holding CHRS